Last 12 months
Inside the activity.
0 purchase rows · 19 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 8 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 20, 2017 Filed Jul 28, 2017 18:02 UTC Amendment |
SWINNEY ROBERT SDirector
|
SaleCommon Stock | 1,700 | $175.00 | $297,500.00 |
DisclosureSEC source: 0001073398-17-000009 · edgardoc.xml · nonDerivative · entry 1 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,593 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2017. F2 · shares: The Form 4, as originally filed, due to broker error, incorrectly reported 4,477 shares sold on behalf of the Reporting Person on July 20, 2017. As such, this Form 4 amends that incorrect transaction previously reported. F3 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| July 20, 2017 Filed Jul 28, 2017 17:57 UTC |
SWINNEY ROBERT SDirector
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 8,500 | $35.00 Strike: $35.00 | $297,500.00 |
DisclosureSEC source: 0001073398-17-000008 · edgardoc.xml · derivative · entry 4 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires 2017-08-14 Read SEC document |
| July 20, 2017 Filed Jul 28, 2017 17:57 UTC |
SWINNEY ROBERT SDirector
|
SaleCommon Stock | 4,477 | $175.00 | $783,475.00 |
DisclosureSEC source: 0001073398-17-000008 · edgardoc.xml · nonDerivative · entry 2 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,816 F1 · security: These securities are Restricted Stock Units. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| July 20, 2017 Filed Jul 28, 2017 17:57 UTC |
SWINNEY ROBERT SDirector
|
OtherCommon Stock | 8,500 | $35.00 | $297,500.00 |
DisclosureSEC source: 0001073398-17-000008 · edgardoc.xml · nonDerivative · entry 1 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,293 Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 00:12 UTC |
Lamb Scott EChief Financial Officer,
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 20,774 | $46.53 Strike: $46.53 | $966,614.22 |
DisclosureSEC source: 0001375852-17-000004 · edgardoc.xml · derivative · entry 7 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires 2022-02-01 F4 · price: Transaction is the exercise of a derivative security; see Column 2. F3 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 00:12 UTC |
Lamb Scott EChief Financial Officer,
|
SaleCommon Stock | 20,774 | $170.00 | $3,531,580.00 |
DisclosureSEC source: 0001375852-17-000004 · edgardoc.xml · nonDerivative · entry 5 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,052 F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 00:12 UTC |
Lamb Scott EChief Financial Officer,
|
OtherCommon Stock | 20,774 | $46.53 | $966,614.22 |
DisclosureSEC source: 0001375852-17-000004 · edgardoc.xml · nonDerivative · entry 4 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,826 Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 00:03 UTC |
Jain VivekDirector · Chairman and CEO
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 27,282 | $58.79 Strike: $58.79 | $1,603,908.78 |
DisclosureSEC source: 0001410442-17-000008 · edgardoc.xml · derivative · entry 11 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 582,366 Underlying: Common Stock · 27,282 shares Expires 2024-02-24 F6 · price: Transaction is the exercise of a derivative security; see Column 2. F5 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the vesting commencement date of February 13, 2014. Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 00:03 UTC |
Jain VivekDirector · Chairman and CEO
|
SaleCommon Stock | 27,282 | $170.00 | $4,637,940.00 |
DisclosureSEC source: 0001410442-17-000008 · edgardoc.xml · nonDerivative · entry 8 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,911 F4 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 00:03 UTC |
Jain VivekDirector · Chairman and CEO
|
OtherCommon Stock | 27,282 | $58.79 | $1,603,908.78 |
DisclosureSEC source: 0001410442-17-000008 · edgardoc.xml · nonDerivative · entry 7 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,193 Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 00:12 UTC |
Lamb Scott EChief Financial Officer,
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 2,998 | $46.53 Strike: $46.53 | $139,496.94 |
DisclosureSEC source: 0001375852-17-000004 · edgardoc.xml · derivative · entry 6 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,774 Underlying: Common Stock · 0 shares Expires 2022-02-01 F4 · price: Transaction is the exercise of a derivative security; see Column 2. F3 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 00:12 UTC |
Lamb Scott EChief Financial Officer,
|
SaleCommon Stock | 300 | $171.00 | $51,300.00 |
DisclosureSEC source: 0001375852-17-000004 · edgardoc.xml · nonDerivative · entry 3 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,052 F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 00:12 UTC |
Lamb Scott EChief Financial Officer,
|
SaleCommon Stock | 2,698 | $170.04 | $458,755.78 |
DisclosureSEC source: 0001375852-17-000004 · edgardoc.xml · nonDerivative · entry 2 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,352 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.00 to $170.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 00:12 UTC |
Lamb Scott EChief Financial Officer,
|
OtherCommon Stock | 2,998 | $46.53 | $139,496.94 |
DisclosureSEC source: 0001375852-17-000004 · edgardoc.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,050 Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 00:03 UTC |
Jain VivekDirector · Chairman and CEO
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 3,704 | $58.79 Strike: $58.79 | $217,758.16 |
DisclosureSEC source: 0001410442-17-000008 · edgardoc.xml · derivative · entry 10 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 609,648 Underlying: Common Stock · 3,704 shares Expires 2024-02-24 F6 · price: Transaction is the exercise of a derivative security; see Column 2. F5 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the vesting commencement date of February 13, 2014. Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days. Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 00:03 UTC |
Jain VivekDirector · Chairman and CEO
|
SaleCommon Stock | 3,704 | $171.00 | $633,384.00 |
DisclosureSEC source: 0001410442-17-000008 · edgardoc.xml · nonDerivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,911 F4 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 00:03 UTC |
Jain VivekDirector · Chairman and CEO
|
OtherCommon Stock | 3,704 | $58.79 | $217,758.16 |
DisclosureSEC source: 0001410442-17-000008 · edgardoc.xml · nonDerivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,615 Read SEC document |
| July 07, 2017 Filed Jul 12, 2017 00:03 UTC |
Jain VivekDirector · Chairman and CEO
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 69,014 | $58.79 Strike: $58.79 | $4,057,333.06 |
DisclosureSEC source: 0001410442-17-000008 · edgardoc.xml · derivative · entry 9 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 613,352 Underlying: Common Stock · 69,014 shares Expires 2024-02-24 F6 · price: Transaction is the exercise of a derivative security; see Column 2. F5 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the vesting commencement date of February 13, 2014. Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days. Read SEC document |
| July 07, 2017 Filed Jul 12, 2017 00:03 UTC |
Jain VivekDirector · Chairman and CEO
|
SaleCommon Stock | 9,854 | $173.22 | $1,706,912.84 |
DisclosureSEC source: 0001410442-17-000008 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,911 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.50 to $173.35, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| July 07, 2017 Filed Jul 12, 2017 00:03 UTC |
Jain VivekDirector · Chairman and CEO
|
SaleCommon Stock | 19,114 | $171.22 | $3,272,695.26 |
DisclosureSEC source: 0001410442-17-000008 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,765 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.00 to $171.75, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| July 07, 2017 Filed Jul 12, 2017 00:03 UTC |
Jain VivekDirector · Chairman and CEO
|
SaleCommon Stock | 40,046 | $170.53 | $6,828,936.26 |
DisclosureSEC source: 0001410442-17-000008 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,879 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.00 to $170.95, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| July 07, 2017 Filed Jul 12, 2017 00:03 UTC |
Jain VivekDirector · Chairman and CEO
|
OtherCommon Stock | 69,014 | $58.79 | $4,057,333.06 |
DisclosureSEC source: 0001410442-17-000008 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,925 Read SEC document |
| May 17, 2017 Filed May 18, 2017 18:09 UTC |
SWINNEY ROBERT SDirector
|
SaleCommon Stock | 594 | $160.92 | $95,585.89 |
DisclosureSEC source: 0001073398-17-000006 · edgardoc.xml · nonDerivative · entry 1 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,793 Read SEC document |
| May 17, 2017 Filed May 18, 2017 17:44 UTC |
BURCAR ALISON DVice President and Gen'l Mgr.
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 14,649 | $61.76 Strike: $61.76 | $904,722.24 |
DisclosureSEC source: 0001189727-17-000005 · edgardoc.xml · derivative · entry 11 BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,649 shares Expires 2023-02-06 F6 · price: Transaction is the exercise of a derivative security; see Column 2. F5 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| May 17, 2017 Filed May 18, 2017 17:44 UTC |
BURCAR ALISON DVice President and Gen'l Mgr.
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 2,160 | $46.53 Strike: $46.53 | $100,504.80 |
DisclosureSEC source: 0001189727-17-000005 · edgardoc.xml · derivative · entry 10 BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,160 shares Expires 2022-02-01 F6 · price: Transaction is the exercise of a derivative security; see Column 2. F5 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| May 17, 2017 Filed May 18, 2017 17:44 UTC |
BURCAR ALISON DVice President and Gen'l Mgr.
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 1,042 | $43.62 Strike: $43.62 | $45,452.04 |
DisclosureSEC source: 0001189727-17-000005 · edgardoc.xml · derivative · entry 9 BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,042 shares Expires 2021-07-20 F6 · price: Transaction is the exercise of a derivative security; see Column 2. F5 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| May 17, 2017 Filed May 18, 2017 17:44 UTC |
BURCAR ALISON DVice President and Gen'l Mgr.
|
OtherCommon Stock | 2,160 | $46.53 | $100,504.80 |
DisclosureSEC source: 0001189727-17-000005 · edgardoc.xml · nonDerivative · entry 8 BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,246 Read SEC document |
| May 17, 2017 Filed May 18, 2017 17:44 UTC |
BURCAR ALISON DVice President and Gen'l Mgr.
|
SaleCommon Stock | 7 | $162.35 | $1,136.45 |
DisclosureSEC source: 0001189727-17-000005 · edgardoc.xml · nonDerivative · entry 7 BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86 F3 · security: Shares were previously acquired through the Registrant's Employee Stock Purchase Plan. Read SEC document |
| May 17, 2017 Filed May 18, 2017 17:44 UTC |
BURCAR ALISON DVice President and Gen'l Mgr.
|
SaleCommon Stock | 432 | $160.90 | $69,507.20 |
DisclosureSEC source: 0001189727-17-000005 · edgardoc.xml · nonDerivative · entry 6 BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93 F3 · security: Shares were previously acquired through the Registrant's Employee Stock Purchase Plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.70 to $161.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 17, 2017 Filed May 18, 2017 17:44 UTC |
BURCAR ALISON DVice President and Gen'l Mgr.
|
SaleCommon Stock | 141 | $162.35 | $22,891.35 |
DisclosureSEC source: 0001189727-17-000005 · edgardoc.xml · nonDerivative · entry 5 BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 525 Read SEC document |
| May 17, 2017 Filed May 18, 2017 17:44 UTC |
BURCAR ALISON DVice President and Gen'l Mgr.
|
SaleCommon Stock | 200 | $161.40 | $32,280.00 |
DisclosureSEC source: 0001189727-17-000005 · edgardoc.xml · nonDerivative · entry 4 BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.30 to $161.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 17, 2017 Filed May 18, 2017 17:44 UTC |
BURCAR ALISON DVice President and Gen'l Mgr.
|
SaleCommon Stock | 17,510 | $160.70 | $2,813,779.96 |
DisclosureSEC source: 0001189727-17-000005 · edgardoc.xml · nonDerivative · entry 3 BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 866 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.175 to $161.150, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 17, 2017 Filed May 18, 2017 17:44 UTC |
BURCAR ALISON DVice President and Gen'l Mgr.
|
OtherCommon Stock | 14,649 | $61.76 | $904,722.24 |
DisclosureSEC source: 0001189727-17-000005 · edgardoc.xml · nonDerivative · entry 2 BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,376 Read SEC document |
| May 17, 2017 Filed May 18, 2017 17:44 UTC |
BURCAR ALISON DVice President and Gen'l Mgr.
|
OtherCommon Stock | 1,042 | $43.62 | $45,452.04 |
DisclosureSEC source: 0001189727-17-000005 · edgardoc.xml · nonDerivative · entry 1 BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,727 Read SEC document |
| May 16, 2017 Filed May 17, 2017 01:23 UTC |
FINNEY ELISHA WDirector
|
Exercise / conversionCommon Stock · Derivative | 743 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-032907 · doc4.xml · derivative · entry 2 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 743 shares Expires 2017-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. Read SEC document |
| May 16, 2017 Filed May 17, 2017 01:23 UTC |
FINNEY ELISHA WDirector
|
Exercise / conversionCommon Stock | 743 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-032907 · doc4.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,105 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| May 16, 2017 Filed May 16, 2017 23:42 UTC |
Greenberg David C.Director
|
Exercise / conversionCommon Stock · Derivative | 743 | $0.00 | $0.00 |
DisclosureSEC source: 0001645866-17-000002 · edgardoc.xml · derivative · entry 3 Greenberg David C. · CIK 0001645866 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 743 shares Expires 2017-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. Read SEC document |
| May 16, 2017 Filed May 16, 2017 23:42 UTC |
Greenberg David C.Director
|
Exercise / conversionCommon Stock | 743 | $0.00 | $0.00 |
DisclosureSEC source: 0001645866-17-000002 · edgardoc.xml · nonDerivative · entry 1 Greenberg David C. · CIK 0001645866 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,535 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| May 16, 2017 Filed May 16, 2017 23:30 UTC |
SWINNEY ROBERT SDirector
|
Exercise / conversionCommon Stock · Derivative | 743 | $0.00 | $0.00 |
DisclosureSEC source: 0001073398-17-000005 · edgardoc.xml · derivative · entry 3 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 743 shares Expires 2017-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. Read SEC document |
| May 16, 2017 Filed May 16, 2017 23:30 UTC |
SWINNEY ROBERT SDirector
|
Exercise / conversionCommon Stock | 743 | $0.00 | $0.00 |
DisclosureSEC source: 0001073398-17-000005 · edgardoc.xml · nonDerivative · entry 1 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| May 16, 2017 Filed May 16, 2017 23:23 UTC |
SHERMAN RICHARD MDDirector
|
Exercise / conversionCommon Stock · Derivative | 743 | $0.00 | $0.00 |
DisclosureSEC source: 0001073391-17-000003 · edgardoc.xml · derivative · entry 2 SHERMAN RICHARD MD · CIK 0001073391 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 743 shares Expires 2017-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. Read SEC document |
| May 16, 2017 Filed May 16, 2017 23:23 UTC |
SHERMAN RICHARD MDDirector
|
Exercise / conversionCommon Stock | 743 | $0.00 | $0.00 |
DisclosureSEC source: 0001073391-17-000003 · edgardoc.xml · nonDerivative · entry 1 SHERMAN RICHARD MD · CIK 0001073391 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,942 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| May 16, 2017 Filed May 16, 2017 23:15 UTC |
SAUCEDO JOSEPH RDirector
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 1,500 | $38.85 Strike: $38.85 | $58,275.00 |
DisclosureSEC source: 0001190251-17-000003 · edgardoc.xml · derivative · entry 9 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2019-07-22 F5 · price: Transaction is the exercise of a derivative security; see Column 2. Read SEC document |
| May 16, 2017 Filed May 16, 2017 23:15 UTC |
SAUCEDO JOSEPH RDirector
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 1,500 | $37.36 Strike: $37.36 | $56,040.00 |
DisclosureSEC source: 0001190251-17-000003 · edgardoc.xml · derivative · entry 8 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2019-10-21 F5 · price: Transaction is the exercise of a derivative security; see Column 2. Read SEC document |
| May 16, 2017 Filed May 16, 2017 23:15 UTC |
SAUCEDO JOSEPH RDirector
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 1,500 | $34.48 Strike: $34.48 | $51,720.00 |
DisclosureSEC source: 0001190251-17-000003 · edgardoc.xml · derivative · entry 7 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2019-04-20 F5 · price: Transaction is the exercise of a derivative security; see Column 2. F4 · derivative.exercise_date: Options exercisable in four equal annual cumulative installments commencing one year after the grant date. Read SEC document |
| May 16, 2017 Filed May 16, 2017 23:15 UTC |
SAUCEDO JOSEPH RDirector
|
Exercise / conversionCommon Stock · Derivative | 743 | $0.00 | $0.00 |
DisclosureSEC source: 0001190251-17-000003 · edgardoc.xml · derivative · entry 6 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 743 shares Expires 2017-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. Read SEC document |
| May 16, 2017 Filed May 16, 2017 23:15 UTC |
SAUCEDO JOSEPH RDirector
|
SaleCommon Stock | 4,500 | $162.51 | $731,272.50 |
DisclosureSEC source: 0001190251-17-000003 · edgardoc.xml · nonDerivative · entry 5 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,091 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.405 to $162.60, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 16, 2017 Filed May 16, 2017 23:15 UTC |
SAUCEDO JOSEPH RDirector
|
OtherCommon Stock | 1,500 | $38.85 | $58,275.00 |
DisclosureSEC source: 0001190251-17-000003 · edgardoc.xml · nonDerivative · entry 4 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,591 Read SEC document |
| May 16, 2017 Filed May 16, 2017 23:15 UTC |
SAUCEDO JOSEPH RDirector
|
OtherCommon Stock | 1,500 | $37.36 | $56,040.00 |
DisclosureSEC source: 0001190251-17-000003 · edgardoc.xml · nonDerivative · entry 3 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,091 Read SEC document |
| May 16, 2017 Filed May 16, 2017 23:15 UTC |
SAUCEDO JOSEPH RDirector
|
OtherCommon Stock | 1,500 | $34.48 | $51,720.00 |
DisclosureSEC source: 0001190251-17-000003 · edgardoc.xml · nonDerivative · entry 2 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,591 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.